ArticleBMC neurology2026
Enhancing risk prediction for cerebral venous thrombosis: evaluation of an integrated approach with clinical CVT probability score and D-dimer levels.
Article in BMC neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDiagnosing cerebral venous thrombosis (CVT) is challenging due to varied symptoms. Computed tomography venography (CTV) or magnetic resonance venography (MRV) are the gold standard, but resource-demanding with potential side effects. We evaluated the diagnostic properties of a previously proposed CVT probability score combined with D-dimer levels in detecting CVT.
methodsMedical records of consecutive adults who underwent CTV or MRV due to suspicion of CVT at a Norwegian primary hospital were retrospectively analyzed. The CVT probability score was calculated based on previous medical history and clinical findings/symptoms at presentation to stratify patients into low, moderate or high CVT probability groups. Performance characteristics were calculated for the CVT probability score with and without D-dimer levels.
resultsAmong 578 patients evaluated from 2016 to 2019, CVT was confirmed in 6.6%. The CVT probability score was available for 444 patients and distributed one-third of CVT patients across each CVT probability group, with a 0.33 sensitivity for each group. A negative predictive value (NPV) of 0.96 was noted for the high CVT probability group. The NPV was 0.99 for the combined low/moderate CVT probability group including D-dimer > 500 µg/L. The positive predictive values were all fairly low.
conclusionOur results indicate that using a CVT probability score and D-dimer levels can help exclude CVT; however, false positive cases present a clinical challenge and carry the risk of excessive advanced imaging.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.